Assignee
GENELABS TECH INC
US·71 granted patents·19 pending applications·1,976 citations·filing 1988–2009
Top patents by PatentIndex Score
90 records- 0195US6849713B2Compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2001·Granted Feb 1, 2005·92 cites·17 claims
- 0295US5538865AHepatitis C virus epitopesGENELABS TECH INC·Filed 1994·Granted Jul 23, 1996·141 cites·2 claims
- 0394US7432248B2Nucleoside derivatives for treating Hepatitis C virus infectionGENELABS TECH INC·Filed 2006·Granted Oct 7, 2008·52 cites·5 claims
- 0494US7064218B2Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2002·Granted Jun 20, 2006·86 cites·36 claims
- 0594US6906103B2Compounds possessing antibacterial, antifungal or antitumor activityGENELABS TECH INC·Filed 2002·Granted Jun 14, 2005·87 cites·6 claims
- 0693US6107023ADNA amplification and subtraction techniquesGENELABS TECH INC·Filed 1988·Granted Aug 22, 2000·185 cites·14 claims
- 0792US7405204B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2006·Granted Jul 29, 2008·40 cites·48 claims
- 0892US7094768B2Nucleoside derivatives for treating hepatitis C virus infectionGENELABS TECH INC·Filed 2004·Granted Aug 22, 2006·47 cites·7 claims
- 0992US6114149AAmplification of mixed sequence nucleic acid fragmentsGENELABS TECH INC·Filed 1991·Granted Sep 5, 2000·192 cites·17 claims
- 1092US5578444ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1993·Granted Nov 26, 1996·82 cites·15 claims
- 1189US7151089B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Dec 19, 2006·37 cites·12 claims
- 1288US7157434B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Jan 2, 2007·35 cites·19 claims
- 1387US7511145B2Bicyclic heteroaryl derivativesGENELABS TECH INC·Filed 2004·Granted Mar 31, 2009·24 cites·11 claims
- 1487US5306619AScreening assay for the detection of DNA-binding moleculesGENELABS TECH INC·Filed 1993·Granted Apr 26, 1994·77 cites·17 claims
- 1586US6951880B2Aryl and heteroaryl compounds as antibacterial and antifungal agentsGENELABS TECH INC·Filed 2003·Granted Oct 4, 2005·28 cites·8 claims
- 1686US5744131ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Apr 28, 1998·53 cites·3 claims
- 1786US5716780AMethod of constructing sequence-specific DNA-binding moleculesGENELABS TECH INC·Filed 1995·Granted Feb 10, 1998·82 cites·9 claims
- 1884US7144868B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Dec 5, 2006·22 cites·21 claims
- 1984US7045513B1DHEA composition and methodGENELABS TECH INC·Filed 2000·Granted May 16, 2006·27 cites·14 claims
- 2083US5738990ASequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Apr 14, 1998·39 cites·5 claims
- 2183US5312837AMethod of treating viral infections with aryl macrocyclic compoundsGENELABS TECH INC·Filed 1991·Granted May 17, 1994·21 cites·8 claims
- 2282US6613517B2Nucleic acid binding assay and selection methodGENELABS TECH INC·Filed 2001·Granted Sep 2, 2003·20 cites·47 claims
- 2382US5766840AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Jun 16, 1998·31 cites·12 claims
- 2480US7189506B1DNA binding compound-mediated molecular switch systemGENELABS TECH INC·Filed 2000·Granted Mar 13, 2007·12 cites·6 claims
- 2580US5693463AMethod of ordering sequence binding preferences of a DNA-binding moleculeGENELABS TECH INC·Filed 1992·Granted Dec 2, 1997·56 cites·3 claims
- 2679US5869241AMethod of determining DNA sequence preference of a DNA-binding moleculeGENELABS TECH INC·Filed 1995·Granted Feb 9, 1999·47 cites·11 claims
- 2777US7425547B2Nucleoside derivatives for treating hepatitis C virus infectionGENELABS TECH INC·Filed 2003·Granted Sep 16, 2008·7 cites·15 claims
- 2875US6869765B2Sequence-directed DNA-binding molecules compositions and methodsGENELABS TECH INC·Filed 2001·Granted Mar 22, 2005·2 cites·1 claims
- 2975US6110662AHTLV-I/HTLV-II assay and methodGENELABS TECH INC·Filed 1994·Granted Aug 29, 2000·37 cites·15 claims
- 3075US6010849ASequence-directed DNA binding molecules compositions and methodsGENELABS TECH INC·Filed 1995·Granted Jan 4, 2000·35 cites·11 claims
- 3173US6552010B1Treatment of SLE with dehydroepiandrosteroneGENELABS TECH INC·Filed 2000·Granted Apr 22, 2003·9 cites·16 claims
- 3272US5726014AScreening assay for the detection of DNA-binding moleculesGENELABS TECH INC·Filed 1993·Granted Mar 10, 1998·39 cites·19 claims
- 3368US7244713B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Jul 17, 2007·3 cites·33 claims
- 3468US7202223B2Nucleoside compounds for treating viral infectionsGENELABS TECH INC·Filed 2004·Granted Apr 10, 2007·3 cites·24 claims
- 3568US6605591B1Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2000·Granted Aug 12, 2003·3 cites·20 claims
- 3666US7169918B2Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivativesGENELABS TECH INC·Filed 2004·Granted Jan 30, 2007·2 cites·51 claims
- 3766US6854468B2Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2003·Granted Feb 15, 2005·2 cites·14 claims
- 3864US5874563AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Feb 23, 1999·15 cites·20 claims
- 3964US5436318AHepatitis C virus epitopesGENELABS TECH INC·Filed 1992·Granted Jul 25, 1995·15 cites·1 claims
- 4062US5849532AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Dec 15, 1998·9 cites·7 claims
- 4162US5824507AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Oct 20, 1998·12 cites·28 claims
- 4261US6838556B2Promoters for regulated gene expressionGENELABS TECH INC·Filed 2001·Granted Jan 4, 2005·1 cites·1 claims
- 4361US5338867APreparation of 4β- amino podophyllotoxin compoundsGENELABS TECH INC·Filed 1992·Granted Aug 16, 1994·9 cites·5 claims
- 4460US7141680B2Aromatic compounds possessing antifungal or antibacterial activityGENELABS TECH INC·Filed 2003·Granted Nov 28, 2006·3 cites·9 claims
- 4560US6355428B1Nucleic acid ligand interaction assaysGENELABS TECH INC·Filed 1999·Granted Mar 12, 2002·20 cites·38 claims
- 4660US5859230ANon-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereofGENELABS TECH INC·Filed 1996·Granted Jan 12, 1999·15 cites·1 claims
- 4760US5856134AHepatitis G virus and molecular cloning thereofGENELABS TECH INC·Filed 1995·Granted Jan 5, 1999·8 cites·6 claims
- 4860US2009081165A1Bicyclic heteroaryl derivativesGENELABS TECH INC·Filed 2008·Application pending·0 cites
- 4959US7612034B2Treatment of subnormal bone mineral densityGENELABS TECH INC·Filed 2004·Granted Nov 3, 2009·0 cites·25 claims
- 5056US2003170714A1Transcripts encoding immunomodulatory polypeptidesGENELABS TECH INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →